Description: Treatment of biopharmaceutical materials; custom manufacture of cells and vectors for diagnostic, medical and commercial applications in relation to cell and gene therapies; consultancy and advisory services relating to the aforesaid services; collections of DNA and gene sequences for research and reference purposes provided as DNA microarrays and DNA chips; Diagnostic preparations and materials generated by the use of base editing components for medical purposes; chemical preparation for use in DNA analysis for medical purposes; biological preparations in the nature of DNA, RNA and parts thereof for medical purposes; biological preparations in the nature of DNA extracts for medical purposes; biological preparations in the nature of gene editing enzymes for medical purposes; biological preparations in the nature of protein cell lysates, genomic DNA preparations and Formalin Fixed, Paraffin Embedded (FFPE) engineered tumour tissue mimics for medical diagnostic use; biological preparations in the nature of biological, biochemical and chemical reagents, including living cells, genetically modified cells and vectors, genomic DNA, cell cultures and mutant and normal isogenic cell line pairs, peptides, proteins and nucleic acids or complexes of these molecules for medical use; all the aforesaid goods being medical preparations; Biological preparations in the nature of eukaryotic cells, isogenic cell lines and bio-production cell lines generated using base editing engineering for scientific, laboratory or medical research; reagents, plasmids and assays for scientific, genetic and medical research; genomic reference control samples for medical laboratory use; molecular biology research tools, in the nature of chemical, biological and biochemical reagents; biological preparations in the nature of separate base editing components including mRNA, rRNA, gRNA, deaminase, nickase, ribonucleotide protein (RNP) for use in scientific, laboratory or medical research; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research and for clinical and industrial use; Custom cell-line engineering services; gene base-editing services for research purposes; gene engineering services; research and development services in the creation of databases or collections of information on biologicals including cells and cell lines for research purposes; creating and providing databases or collections of information on normal and mutated genes for research purposes; providing DNA reference standards for research purposes; providing DNA reference databases being collections of DNA and gene sequences for research purposes; research on cell line models; contract research on cell line models; research and development services relating to targeting therapies to individuals; establishing patient genotypes for research or analysis purposes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling for research purposes; design of clinical trials for research purposes; research and development in re-positioning existing drugs from other therapeutic indications; consultancy and advisory services relating to the aforesaid services; all of the aforesaid services relating to biological and medical research and research and development in the field of cells and cell therapies, genome editing, genetic engineering and gene therapies
